This book is a rich source of information on point-of-care (POC) tests for the diagnosis and treatment of severe hemorrhage, including thromboelastography, thromboelastometry, heparin monitoring systems, and platelet function analyzers (Multiplate, PFA-100, VerifyNow, etc.). The opening chapters focus on the pathophysiology of coagulation and the general characteristics of POC devices. The relevance of POC tests in specific scenarios is then carefully explained, with guidance on their use in contexts including trauma, cardiovascular surgery, ECMO, liver surgery, postpartum hemorrhage, and disorders of hemostasis in the critically ill. An individual chapter is devoted to practical issues when applying POC tests, and the book closes by presenting a set of informative clinical cases. As POC devices gain increasing popularity as bedside diagnostic tools in different clinical settings, it is important for practitioners to understand their role and value. Point-of-Care Tests for Severe Hemorrhage will ...
[105 Pages Report] Check for Discount on Global Point-Of-Care Devices Market Professional Survey Report 2016 report by QYResearch Group. Notes: Production, means the output of Point-Of-Care Devices...
Objective: To determine the uptake of current antenatal HIV testing, the prevalence of risk factors for HIV in pregnant women and the acceptability of the Rapid Point-of-Care HIV Test (RPOCT) amongst pregnant women and their midwives. Design: A retrospective review of 717 notes to determine current HIV screening practices and a cross- sectional survey using a self-completed questionnaire for pregnant women and midwives. Setting: The Antenatal Clinic (ANC) and Postnatal wards (PNW) at a University teaching hospital in the West Midlands. Participants: 486 women attending the ANC or admitted to the PNW during a fortnight in May-June 2006 and 72 midwives on the delivery ward completed a second questionnaire. Results: From the questionnaire, it was determined that 90.4% of those offered the standard HIV test accepted it, with 7.2% having at least 1 risk factor for HIV. Of the decliners, over half perceived themselves not at risk. 85.2% would accept the rapid test, including 35.6% of those who ...
This is a diagnostic validation study for a combined Syphilis/HIV test made by MBio Diagnostics, Inc (MBio, Boulder, CO, USA). Although the MBio Syphilis/HIV diagnostic platform is designed for use at point of care (POC), it is made to provide similar performance as reference standards. Diagnosing HIV and syphilis accurately with a single POC test will save time for clinic health workers and technicians, reduce loss-to follow-up caused by lengthy delays for lab-based tests, and save costs by eliminating the need for multiple tests. For this study, the sensitivity and specificity of the MBio HIV/Syphilis Serology System point-of-care diagnostic test will be determined using reference tests performed under controlled laboratory conditions. For this, clients receiving routine care in the ANCs at the New Nyanza Provincial General Hospital (NNPGH) and Kisumu District Hospital (KDH) will be consented to provide blood for the proposed study. Study volunteers will receive HIV and syphilis rapid tests ...
TY - JOUR. T1 - Feasibility of a point-of-care test based on quantum dots with a mobile phone reader for detection of antibody responses. AU - Cysticercosis Working Group in Peru. AU - Lee, Chan. AU - Noh, John. AU - ONeal, Seth E.. AU - Gonzalez, Armando E.. AU - Garcia, Hector H.. AU - Handali, Sukwan. PY - 2019/10/1. Y1 - 2019/10/1. N2 - We developed a novel and portable fluorescent sensor that integrates a lateral flow assay with a quantum dot (Qdots) label and a mobile phone reader for detection of specific antibodies in human serum. We evaluated the utility of this assay to test for antibodies to the Taenia solium rT24H antigen. It was a retrospective study by examining 112 positive human sera from patients with neurocysticercosis (NCC) including samples from patients with single viable cyst (n = 18), two or more viable cysts (n = 71), and subarachnoid (racemose) cysts (n = 23). These samples were collected from previous study subjects in Lima, Peru under an approved study protocol in ...
MEDFORD, N.Y., Sept. 26, 2016-- Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases, today announced that the Company has been awarded a grant from the United States Department of Agriculture to develop a POC diagnostic test for bovine tuberculosis. The $600,000 grant is managed by the Small Business Innovation Research...
Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy Steven D Reid, Sarah J Fidler, Graham S Cooke Department of Infectious Diseases, St Mary's Hospital, Imperial College London, London, UK Abstract: It is now around 30 years since the discovery of HIV, the virus that causes AIDS. More than 70 million people have been infected in that time and around 35 million have died. The majority of those currently living with HIV/AIDS are in low- and middle-income countries, with sub-Saharan Africa bearing a disproportionate burden of the global disease. In high-income countries, the introduction of antiretroviral therapy (ART) has drastically reduced the morbidity and mortality associated with HIV. Patients on ART are now predicted to have near-normal life expectancy and the role of treatment is increasingly recognized in preventing new infections. In low- and middle-income countries, treatment is now more widely available and around half of those who need ART are
The details of bibliography - The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence
Clozapine remain the drug of choice for treatment resistant schizophrenia and up to 60% of patients not responding to other antipsychotics will respond to clozapine. However, the use of clozapine is restricted due to the risk of agranulocytosis and consequently the need for mandatory hematological monitoring. CHEMPAQ XBC is a point-of-care device that can be used in patients home and analyze WBC and granulocytes by a single capillary blood drop. This study aims to investigate whether this new procedure increases the acceptability of ...
Background Rapid point-of-care (POC) assessment of hemostasis is certainly clinically important in patients with a variety of coagulation factor and platelet defects who have bleeding disorders. distinguishing among coagulation disorders as compared to conventional screening coagulation tests. Moreover, the ClotChip r,max parameter detected platelet function inhibition induced by aspirin and exhibited strong positive correlation with light transmission aggregometry. Conclusions This study demonstrates that ClotChip assesses multiple aspects of the hemostatic process in whole blood on a single disposable cartridge, highlighting its potential as a POC platform for rapid, comprehensive hemostatic analysis. Introduction Early identification of hemostatic dysregulation and bleeding risk is important in the management of patients who are critically ill, severely injured, or on antiplatelet/anticoagulation therapies [1]. order Iressa Conventional laboratory-structured coagulation exams are time-eating, ...
This project is part of the EDCTP2 programme supported by the European Union. Abstract. Tuberculosis kills ~1.4 million people annually and is a leading cause of death in sub-Saharan Africa. Sensitive and rapid point-of-care tests are expected to substantially reduce TB incidence and mortality, however, until recently, tests that meet these criteria are yet to become available. We propose a package of novel diagnostic studies to build local capacity and evaluate the feasibility, accuracy, and effectiveness of new, ultra-sensitive point-of-care tests for TB and drug-resistance in our high-burden, high HIV setting of Cape Town, South Africa.. Firstly, we will evaluate the accuracy and impact of Xpert Ultra (using the Omni system) and AlereQ TB testing for pulmonary TB at the point-of-care in clinics (n=360 patients). These tests, which likely have sensitivity equivalent to a culture, may have utility in patients with few or no symptoms (~1 in 5 TB cases are missed by screening algorithms). We will ...
San Francisco, July 11, 2016-- The global Point-of-Care Diagnostics market is anticipated to reach USD 20.9 billion by 2024, according to a new report by Grand View Research, Inc. Rise in the R&D funding and research activities amongst the market players in order to introduce novel POC tests and devices for ease of disease detection and monitoring is expected...
SARASOTA FL (PRWEB) October 12 2017 RPS Diagnostics Inc. (RPS®) today announces publication of a United States multicenter prospective clinical study that dem,Clinical,Study,Demonstrates,that,RPS,Diagnostics,FebriDx,Rapid,Point-of-Care,Blood,Test,Can,Accurately,Distinguish,Between,Acute,Bacterial,and,Viral,Respiratory,Infection,biological,advanced biology technology,biology laboratory technology,biology device technology,latest biology technology
To measure CD4 T-cells, the prime indicator of HIV disease progression, a new point-of-care test can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve clinical outcomes.
This document contains guidelines for performance of point-of-care blood glucose meter systems that stress quality control, training, and administrative responsibility. CLSI Approved Guideline.
Author(s): Ogle, Kathleen; Mandoorah, Sohaib; Fellin, Matthew; Shokoohi, Hamid; Probasco, William; Boniface, Keith | Abstract: Musculoskeletal complaints are one cornerstone of urgent issues for which orthopedic and emergency physicians provide care. Ultrasound can be a useful diagnostic tool to help identify musculoskeletal injuries. We describe a case of bilateral patellar tendon rupture that presented after minor trauma, and had the diagnosis confirmed at the bedside by point-of-care ultrasound.Physicians caring for patients with orthopedic injuries should be familiar with the use of ultrasound to diagnose tendon ruptures.
A 16-year-old male presented with three months of palpitations at rest, fatigue, and episodic pre-syncope; his paternal grandfather died following presumed premature myocardial infarction at age 30. He was seen and discharged one week previously at an outside emergency department (ED). He followed up with his pediatrician and was promptly referred to our pediatric ED for evaluation given his risk factors. Pertinent vitals on arrival were pulse 110, blood pressure 129/66, and oxygen saturation 97% on room air. His exam was remarkable for a left upper sternal border 2/6 holosystolic murmur with radiation to apex. In addition, the patient had a chest radiograph (Figure), a nonspecific but abnormal EKG, and a point-of-care ultrasound (POCUS) of the heart performed.. ...
EDE (Emergency Department Echo) Point-of-Care Ultrasound is the most highly rated introductory ultrasound course in North America.
As perioperative anesthesiologists, we work in a fast-paced environment where we often have to make critical decisions for patients with rapidly evolving pathology and clinical scenarios. These potentially life-saving interventions are made without the luxury of time for a complete assessment or ordering of advanced imaging. Therefore, emergencies inherently result in gaps in clinical evidence and the potential for suboptimal management.. The idiom "seeing is believing" means that only physical or concrete (i.e., visible) evidence is convincing. In these emergent and critical scenarios, point-of-care ultrasound (PoCUS) has proven to be a powerful tool to obtain concrete evidence to either confirm or rule out severe and potentially life threatening conditions.. ...
Tenth Annual Ultrasound-Guided Cadaver Course for Regional Anesthesia and Point-of-Care Ultrasound: 1) In the Advanced Neuraxial track, interfascial
Point-of-care diagnostics, IBM research. Microchip used for diagnostics (lab on a chip) as developed by IBM scientists Luc Gervais and Emmanuel Delamarche at IBM Research-Zurich, Switzerland. This IBM system uses an innovative silicon chip and can test for many diseases, including cardiovascular disease. It can also test for chemical and biological hazards and monitor medicinal therapies. The microchip measures 1 by 5 centimetres. Photographed in September 2009. - Stock Image C022/8413
DUBLIN, July 19, 2016 /PRNewswire/ -- Point-of-Care Diagnostics Market Worth USD 36.96 Billion by 2021 - Increasing Inclination Towards Home Healthcare -...
Background: Measurement of glycosylated hemoglobin (HbA1c) levels is standard of care in assessment of glycemic control among diabetes mellitus patients. Traditional high performance liquid chromatography (HPLC) based tests are expensive, need specialized equipment, and have a longer turn-around-time. Point-of-care tests to estimate HbA1c levels are now commercially available but with only limited studies from developed nations. We performed this study to understand diagnostic accuracy of two commercially available HbA1c point-of-care test. Methods: The study was conducted in an urban and a rural outpatient clinic in central India. We compared HbA1c estimated from two index tests (Hemocue Hb501, Sweden; SD Biosensor, South Korea) from capillary blood samples and compared it with HPLC, as a reference standard in an independent and a blinded manner. We estimated diagnostic accuracy of the index tests as compared to the reference standard. Results: The area under Reciever Operating Curve (ROC) for
Abbott (formally Alere) diagnostics and point of care solutions for better information and better decisions. Find out more about our best-in-class products.
Alere diagnostics and point of care solutions for better information and better decisions. Find out more about our best-in-class products.
Background:. Volatile organic compounds (VOCs) in breath have been reported as biomarkers of breast cancer and abnormal mammograms, apparently resulting from increased oxidative stress and cytochrome p450 induction. We evaluated a six-minute point-of-care breath VOC assay at three breast cancer screening centers in USA and the Netherlands.. Methods:. 244 women had a screening mammogram (93/37 normal/abnormal) or a breast biopsy (cancer/no cancer 35/79). A mobile point-of-care system collected and concentrated breath and air VOCs for analysis with gas chromatography and surface acoustic wave detection. Chromatograms were segmented into a time series of alveolar gradients (breath minus room air). Segmental alveolar gradients were ranked as candidate biomarkers by C-statistic value (area under curve [AUC] of receiver operating characteristic [ROC] curve). Multivariate predictive algorithms were constructed employing significant biomarkers identified with multiple Monte Carlo simulations and ...
This thesis presents technological advancements in microfluidics. The overall goals of the work are to develop new miniaturized tests for point-of-care diagnostics and robust super-lubricating surfaces for friction reduction. To achieve these goals, novel materials, surfaces and manufacturing methods in microfluidics have been developed.. Point-of-care diagnostic tests are portable miniaturized instruments that downscale and automate medical tests previously performed in the central laboratories of hospitals. The instruments are used in the doctors office, in the emergency room or at home as self-tests. By bringing the analysis closer to the patient, the likelihood of an accurate diagnosis, or a quick therapy adjustment is increased. Already today, there are point-of-care tests available on the market, for example blood glucose tests, rapid streptococcus tests and pregnancy tests. However, for more advanced diagnostic tests, such as DNA-tests or antibody analysis, integration of microfluidic ...
Dual antiplatelet therapy is important treatment modality across the spectrum of coronary artery disease manifestations. However, a significant number of patients do not have a completely effective re
Dr. Rose and his team are developing an innovative microfluidics-based platform for point-of-care molecular detection of a broad range of respiratory pathogens. Over 220 million people worldwide suffer from respiratory infections each year. This number is expected to increase by 10-20% annually over the next decade, creating demand for tests to differentiate between infectious diseases with similar symptoms, especially in low-resource settings. The proposed product, under development by Micronics, Inc. (Redmond, WA), is a microfluidics cartridge that will operate in a compact battery-operated instrument, permitting diagnostic assays to be performed rapidly in low-resource settings at minimal cost. All reagents for specimen processing, PCR-based target amplification, detection, and read-out are integrated into a disposable cartridge. A unique feature is Dr. Roses CODEHOP PCR primer technology, which permits broad detection of related viruses in a single assay. The goal of the proposed work is to ...
A report from Progressive Markets says that the global point-of-care diagnostic market is expected to grow at a CAGR of 9.4% from 2017 to 2025. Point-of-care (POC) or bedside testing is now much easier with reliable point-of-care diagnostic devices available in the market. Advanced devices such as point-of-care drug test cups and handheld analyzers can [...] ...
The results of HPV detection in 550 cervical samples by cervical cytology were compared with the sequencing analysis and HPV genotyping 9G membrane test. The HPV genotyping 9G membrane test can efficiently identify and discriminate five HR-HPV genotypes. The 100% identical results of HPV genotyping 9G membrane tests with the sequencing results in 550 clinical samples ensure its wide clinical applicability. The simple handling steps and the portable scanning device make the HPV genotyping 9G membrane test applicable in point-of-care settings. Moreover, the HPV genotyping 9G membrane test allows one to obtain final results in 30 min at 25 °C by simply loading the hybridization and washing solution and scanning the membranes without any drying steps or special handling. The clinical sensitivity and specificity of the HPV genotyping 9G membrane test was found to be 100%, which is much higher than cervical cytology.
Evidence reviews synthesize the available research on a specific HIV or hepatitis C prevention, testing, treatment, care or support approach.. Disclosure programming - This review examines the evidence related to HIV disclosure and focuses on disclosure to sexual partners, family and friends.. Health Navigation - A review of the evidence to support the impact of health navigation on screening, testing and diagnosis, care, and treatment.. Does multidisciplinary care improve health outcomes among people living with HIV and/or HCV? - A review of the scientific literature found that people living with HIV and/or hepatitis C who access the services of a multidisciplinary care team are more likely to achieve optimal health outcomes, and in the case of hepatitis C, a cure.. Rapid point-of-care HIV testing - A review of the evidence to support the impact of rapid point-of-care testing on HIV testing uptake, acceptability, receipt of results and other outcomes.. HIV point-of-care testing in Canadian ...
This sample first pathway, which enabled the real-life impact of rapid and POC test introduction into our SHC, was highly acceptable, demonstrated by ,90% of those providing feedback in favour of giving samples on arrival and receiving results in the same clinical visit.. This is the first report of absolute times waited for the CT/NG GeneXpert, as opposed to willingness to wait.16 ,23 Results from microscopy and non-NAAT POCTs were all available by time of consultation and compared with the standard clinical pathway, resulted in increased numbers of diagnoses at first visit, compared with routine microscopy alone, leading to an increased number of treatments given. This had potential benefits of reducing duration of infection and risk of transmission to sexual partners.. In stark contrast, CT/NG results were available in time for only a fifth of patients, with GeneXpert processing times too long to impact on the majority of patients clinical care, a finding consistent with previous ...
Dr Ellen Jo Baron, Emeritus Professor of Pathology at the Stanford University Medical Center and associated with Cepheid, gave the example of Cepheids Xpert HIV1 Viral Load assay which is strictly not a point-of-care test. But it can be done in a small laboratory that has necessary resources. It is fully automated, can identify all the sub-types and gives results in 90 minutes. Dr Baron shared that Cepheid has got a grant to create a finger-stick test for viral load testing, which is battery operated, portable, rugged, relatively affordable, can be run on omni instrument at remote sites. It is hoped to give results in less than 60 minutes, with an accuracy of 500 copies/ml ...
Intraperitoneal rectal injuries will cause. peritonitis, sepsis and even death if not detected early. Intraperitoneal free air (IFA) is usually diagnosed by an erect Chest X-ray [2]. If the erect chest X-ray was normal, then an abdominal CT scan is recommended. Point-of-care ultrasound has been recently used to detect IFA [3, 4]. Hereby, we report an unusual case of trans-anal rectal injury in which point-of-care ultrasound was of a great help for an early diagnosis. Case presentation A 45-year-old male presented to the Emergency Department complaining of lower abdominal pain and dysuria of two days https://www.selleckchem.com/products/ON-01910.html duration. His blood pressure was 120/80 mmHg, his pulse was 107 beat per minute and his temperature Mocetinostat supplier was 36.8°C. Abdominal examination revealed tenderness and. guarding in the lower find more abdomen. Surgeon-performed portable point-of-care ultrasound as an extension of the abdominal examination was done immediately and ...
ProAxsis was delighted to see its ProteaseTag® technology incorporated in to an important study presented at the European Cystic Fibrosis Society Conference, which took place between June 7th-10th in Seville. The study, which was conducted at Stanford University by Burgener and colleagues*, utilised the ProteaseTag® Active NE Immunoassay to associate Pf bacteriophage with higher levels of Pseudomonas aeruginosa and active neutrophil elastase in patients with CF.. At the same conference, the company presented data on the quantification of active neutrophil elastase (NE) using different sputum processing techniques. The study, with lead author Dr Charlene Robb, concluded that a basic sputum processing technique, which can be quickly and easily performed within a clinical setting, could be suitable for assessment of active NE, and may be combined with a rapid point-of-care test in the future, for quick clinical evaluation.. Dr David Ribeiro, CEO of ProAxsis, said: "It is very pleasing for the ...
Sensitivity of the near patient test is lower than that of cell culture and PCR. So, the use of NPT for individual diagnosis is of limited benefit because in case of a negative result, interpretation is difficult. However, the high specificity of some of these tests (8,12,17) make them a valuable tool for the surveillance of influenza. The major point of interest of this surveillance is the speed with which information about circulation of influenza viruses can be obtained, information which is usually confirmed an average of nine days later using the classical surveillance systems (14). This time gain was observed in Switzerland during all four seasons, in France (13) and in Hawaii (15). This rapid detection and reporting of influenza viruses allows the public health services to take the necessary precautions for an epidemic and helps physicians to confirm their diagnoses of influenza (7). As a consequence, this information allows appropriate use of antiviral drugs against influenza only during ...
At the end of 2015, we began a pilot study - Pre-hospital Assessment Rotterdam Aortic Aneurysm (PARA2) - to evaluate pre-hospital assessment of the abdominal aorta using point-of-care ultrasound (POCUS). FUJIFILM Sonosite provided two hand-carried ultrasound systems and, together with an emergency physician with extensive POCUS experience, trained three ambulance nurses and two nurse practitioners to scan the abdominal aorta. It quickly became part of our daily routine to scan patients aortas, gaining as much practice as possible. As nurse practitioners, we also received more advanced training in point-of-care ultrasound, including Extended Focused Assessment with Sonography for Trauma (eFAST), to allow additional conditions to be triaged.". https://www.sonosite.com/blog/pocus-pre-hospital-settings-rotterdam-netherlands. ...
Portable Biosensors and Point-of-Care Systems describes the principles, design and applications of a new generation of analytical and diagnostic biomedical devices, characterized by their very small size, ease of use, multi-analytical capabilities and speed to provide handheld and mobile point-of-care (POC) diagnostics. The book is divided in four Parts. Part I is an in-depth analysis of the various technologies upon which portable diagnostic devices and biosensors are built. In Part II, advances in the design and optimization of special components of biosensor systems and handheld devices are presented. In Part III, a wide scope of applications of portable biosensors and handheld POC devices is described, ranging from the support of primary healthcare to food and environmental safety screening. Diverse topics are covered, including counterterrorism, travel medicine and drug development. Finally, Part IV of the book is dedicated to the presentation of commercially available products including a review
This new 835-page report from VPGMarketResearch contains 80 tables, and provides a comprehensive analysis of thePOC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. Rationale. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient ...
The early beginning of an adequate antibiotic therapy is crucial in hospital-acquired pneumonia (HAP), but depends on the results of conventional microbiological diagnostics (cMD). It was the aim of this study to evaluate the performance and turnaround times of a new point-of-care multiplex polymerase chain reaction (mPCR) system for rapid identification of pathogens and antibiotic resistance markers. We assessed the applicability of the system under real-life conditions in critical ill patients with HAP. We enrolled forty critical ill patients with clinical signs for HAP into an observational study. Two samples of respiratory secretions were collected during one course of aspiration and cMD and mPCR testing (Unyvero, Curetis AG, Holzgerlingen, Germany) were performed immediately. The mPCR device was operated as a point-of-care system at the intensive care unit. We compared turnaround times, results of pathogen identification and results of antibiotic resistance testing of both methods. Mean turnaround
BOTHELL, WA, August 19, 2002 - Unveiling the smallest all-digital ultrasound platform available in the world-- the three-pound iLook series-- hand-carried ultrasound pioneer SonoSite, Inc., has enabled acceleration in the routine application of visual medicine. Just larger than a PDA, iLook was developed to enable greater access to visualization technology across an array of medical specialties - ultimately putting a new high-powered tool in the hands of healthcare providers that can facilitate improvements in quality of care while reducing healthcare costs.. iLook is designed to further increase the utility of hand-carried ultrasound in patient care. Hand-carried ultrasound is gaining acceptance because it enables a trained physician immediately to obtain information that can help diagnose a patients condition or guide a delicate procedure such as a biopsy or a vascular line placement -- but without increasing the complexity of the procedure itself or the costs to the hospital ...
As infliximab was one of the first therapeutic monoclonal antibodies on the market to treat inflammatory bowel disease and as treatment alternatives were limited, many data exist on how to optimize the treatment with infliximab. Since a drug can only exert its function when adequate concentrations are achieved in the serum, it was soon discovered that the concentrations of infliximab just before the next dose administration (i.e. trough concentrations) can be linked to clinical response. Patients with low trough concentrations are more prone to relapse and can benefit from a dose intensified therapy regimen. In the laboratory for Therapeutic and Diagnostic Antibodies, enzyme-linked immunosorbent assays to determine the concentration of infliximab have been developed and recently optimized using specific, monoclonal anti-infliximab antibodies to detect infliximab. In addition, our lab aims to develop rapid point-of-care assays for the detection of infliximab allowing immediate dose optimization ...
Point-of-care ultrasonography (POCUS) is a widely used tool in emergency and critical care settings, useful in the decision-making process as well as in interventional guidance. While having an impressive diagnostic accuracy in the hands of highly skilled operators, inexperienced practitioners must be aware of some common misinterpretations that may lead to wrong decisions at the bedside. This article provides a revision list of common POCUS misdiagnoses usually found in practice and offers useful tips to recognize and avoid them. The following aspects were selected and reviewed: pericardial effusion vs. pleural vs. ascites vs. epicardial fat; right ventricle dilation in acute pulmonary embolism and inferior vena cava for volume status assessment in cardiac ultrasound; lung point and lung pulse misinterpretations and mirror artifacts vs. lung consolidations in lung ultrasound; peritoneal fluid vs. the stomach and a critical appraisal of gallbladder signs of acute cholecystitis in abdominal ultrasound;
Positive predictive value (PPV) and negative predictive value (NPV) - Positive predictive value is the probability that subjects with a positive point-of-care test truly have the bacteria present. Negative predictive value is the probability that subjects with a negative point-of-care test truly do not have the bacteria present. ...
At present, monitoring the virus in patients presents a logistical challenge, even in wealthy areas. In such places, an HIV-positive patients blood may be drawn every six months by a trained nurse and stored in $40 worth of reagents, refrigerated and sent to a laboratory where a skilled technician uses a laser-equipped machine costing around $100,000 to count the CD4 immune cells in the patients blood. If the count drops below certain thresholds, such as 350 cells per milliliter, implying damage from HIV, the patients caregivers may initiate antiretroviral therapy or change to a new therapy if an existing one is no longer working. If treatment happens early enough, it can fend off the HIV infection before the patients immune system is weak enough to allow an opportunistic infection such as tuberculosis. Follow-up tests can help caregivers decide whether the treatment is working and whether to switch to backup drugs.. In resource-poor settings, testing and monitoring the infection might ...
disposable cardiac biomarker strips and an electronic reader. Once implemented, it will be connected to the AI platform that will continuously collects patients health information from patient s daily manual log, electronic medical record, and remotely monitor the patient s quality of life (QoL) and their medication adherence, thus helping patients manage their condition better.. ...
Despite the recent technological advancements in TB diagnosis, the logistical challenges of health care in developing countries, where TB is most prevalent and also most under-treated, has to be recognized. It is necessary to develop methods and technologies to identify TB, as wells as MDR and XDR TB strains. The technology must be readily applicable to point-of-care situations, it must be affordable and cannot require an advanced level of skill or laboratory settings. The smear negative culture positive group is of interest in a country like South Africa where HIV co-infection leads to paucibacillary. In these individuals, the sensitivity of smear microscopy, the most widely used technique at primary health care levels, is reduced. The development of a diagnostic system that is affordable (, than 4$ per assay), rapid (, than 1 hour), mobile and highly accurate will be discussed. The lysis efficiency of the developed system, in combination with a multiplex PCR protocol, resulted in an improved ...
Michael S. Singer M.D. Ph.D. Harvard Medic...Atherosclerosis is the fundamental process in coronary artery di...At the root of atherosclerosis is a disturbance of the inner (intim...Despite the central role of the artery in coronary and cerebrovascu...,New,Point-of-Care,Methods,to,Measure,Coronary,and,Cerebrovascular,Risk,medicine,advanced medical technology,medical laboratory technology,medical device technology,latest medical technology,Health
Jani et al. implemented point-of-care counting of CD4 cells in Mozambique to assess the effect on loss to follow up. Findings indicated that point of care CD4 testing enabled clinics to stage patients rapidly on-site after enrolment, which reduced opportunities for pretreatment loss to follow up, and enabled the identification and treatment of more patients eligible for ART.. The article is available online at: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61052-0/fulltext ...
Australia. Professor Mark Shephard OAM, BSc (Hons), MSc, MAIMS, MAACB, FFSc (RCPA), PhD is Director of the Flinders University International Centre for Point-of-Care Testing. He is Program Manager of the international ACE (Analytical and Clinical Excellence) Point-of-Care Testing Program for diabetes management which is now operating in 7 countries, and is the Course Co-ordinator for the Centres Graduate Certificate in Global Point-of-Care Testing, which is the first postgraduate academic qualification in the field of point-of-care testing. Within Australia, Mark is Program Manager of the largest national point-of-care testing field network, called QAAMS (Quality Assurance for Aboriginal and Torres Strait Islander Medical Services), which delivers point-of-care testing for diabetes management in over 175 Aboriginal medical services. He is also Chair of the Management Committee of the Northern Territory Point-of-Care Testing Program, in which point-of-care testing for acute and chronic diseases ...
Australia. Professor Mark Shephard OAM, BSc (Hons), MSc, MAIMS, MAACB, FFSc (RCPA), PhD is Director of the Flinders University International Centre for Point-of-Care Testing. He is Program Manager of the international ACE (Analytical and Clinical Excellence) Point-of-Care Testing Program for diabetes management which is now operating in 7 countries, and is the Course Co-ordinator for the Centres Graduate Certificate in Global Point-of-Care Testing, which is the first postgraduate academic qualification in the field of point-of-care testing. Within Australia, Mark is Program Manager of the largest national point-of-care testing field network, called QAAMS (Quality Assurance for Aboriginal and Torres Strait Islander Medical Services), which delivers point-of-care testing for diabetes management in over 175 Aboriginal medical services. He is also Chair of the Management Committee of the Northern Territory Point-of-Care Testing Program, in which point-of-care testing for acute and chronic diseases ...
Coagulopathy occurs in 1 in for severely injured trauma patients, but there is no suitable point-of-care device that can test for bleeding risk in a trauma patient. For this reason, we have developed and tested a bench-top prototype in which blood samples can be tested for coagulopathy using a microfluidic card. The prototype develop with this LSDF grant uses a portable computer and custom software to control each subsystem. A syringe pump is operated by the software to flow a small sample of blood into the microfluidic card. A commercial heater controller is used to maintain the microfluidic card and blood sample at 37°C. A custom-built, miniature fluorescent microscope acquires video images of coagulation in the microfluidic card for real-time analysis. The prototype is a complete, stand-alone system that has a small footprint. It will be used for in vitro testing and clinical studies for coagulopathy ...
True Diagnostics, Carlsbad, CA, received CE approval for a quantitative TSH (Thyroid Stimulating Hormone) test on the TrueDx platform. This new platform is
The BD FACSPresto™ Near-Patient CD4 Counter was developed to expand HIV/AIDS management in resource-limited settings. It measures absolute CD4 counts (AbsCD4), percent CD4 (%CD4), and hemoglobin (Hb) from a single drop of capillary or venous blood in approximately 23 minutes, with throughput of 10 samples per hour. We assessed the performance of the BD FACSPresto system, evaluating accuracy, stability, linearity, precision, and reference intervals using capillary and venous blood at KEMRI/CDC HIV-research laboratory, Kisumu, Kenya, and precision and linearity at BD Biosciences, California, USA ...
In organ transplantation, infection and rejection are major causes of graft loss. They are linked by the net state of immunosuppression. To diagnose and treat these conditions earlier, and to improve long-term patient outcomes, refined strategies for the monitoring of patients after graft transplantation are needed. Here, we show that a fast and inexpensive assay based on CRISPR-Cas13 accurately detects BK polyomavirus DNA and cytomegalovirus DNA from patient-derived blood and urine samples, as well as CXCL9 messenger RNA (a marker of graft rejection) at elevated levels in urine samples from patients experiencing acute kidney transplant rejection. The assay, which we adapted for lateral-flow readout, enables-via simple visualization-the post-transplantation monitoring of common opportunistic viral infections and of graft rejection, and should facilitate point-of-care post-transplantation monitoring. A fast and inexpensive point-of-care assay based on CRISPR-Cas13 accurately detects the DNA of
... Summary GlobalDatas Medical Devices sector report,
Dates: October 12, 2017; March 1, 2018Location: West Bank Office BuildingFamily Medicine POCUS serves as an introduction to family medicine ultrasound. Participants learn and practice techniques through lecture and hands-on training taught by faculty.
Dear members of the ASRA community,. I wanted to highlight the utility of the work done by Drs. Van de Putte and Perlas on the use of gastric ultrasound to assess the gastric volume, which recently altered my anesthetic induction plan. In this case, an obese female of middle age, who suffered from a motor vehicle accident 24 hours prior, was scheduled for pelvic fracture fixation surgery. The patient also sustained a cervical fracture (C1-2) and her cervical collar was recommended by the neurosurgical team to be kept on at all times. This patient definitely had a higher risk of aspiration of gastric contents, with gastric dysmotility due to her recent accident, pain, and the use of opioids for pain management. Awake intubation would have been the most conservative approach. though the patient was exceedingly anxious about the prospect. In order to decide upon the true necessity of awake intubation, we performed a gastric ultrasound. We were able to identify the gastric antrum in her case and ...
... “2015 New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, - Market research report and industry analysis - 9079984
by Rich Fabian, Chief Operati Rich Fabian, SonoSites COO, comments on an article describing three problems that Australian providers and patients face when it comes to the use of POCUS in Australian Emergency Departments.
Since their introduction in 1997, "smart" mobile phones with internet connectivity, high resolution cameras, touch-screen displays, and powerful CPUs have gained rapid market acceptance driven by a combination of falling prices and increasingly sophisticated features. In addition, there is a growing ecosystem of applications that take advantage of the phones sensors, display, and connection to powerful computing and data storage capabilities that are available in the "cloud." The built-in capabilities of smartphones can be further extended through the addition of accessories that enable the phone to sense different types of information. Incorporation of biosensing into mobile platforms is a potentially powerful development, as biological assay capabilities that have previously only been available through expensive laboratory-based instruments may be utilized by anyone. Such developments may help to facilitate the goal of "personalized medicine" in which home-based tests may be used to diagnose ...
March 10, 2008 - Testing hospitalized patients for drug-resistant infections can help reduce mortality, decrease length of stay and reduce cost of care, according to a new study recently released by AdvaMed, the Advanced Medical Technology Association. The report describes how diagnostic testing can identify drug resistance, allowing physicians to adjust medications or take other steps to more effectively treat patients with staphylococcal (staph) and other infectious diseases such as HIV and tuberculosis. Testing is being made easier with the introduction of new point-of-care tests for MRSA detection, which can identify carriers with a nasal swab within one or two hours.. "These findings show such large benefits in cost savings and health outcomes that antimicrobial susceptibility tests should be performed on all patients with these diagnoses," said report author Frank Lichtenberg, Ph.D., professor of business, Columbia University Graduate School of Business. "Widespread testing for ...
Airway Studies: Pubmed Collection Adhikari S, Zeger W, Schmier C, Crum T, Craven A, Frrokaj I, Pang H, Shostrom V. Pilot study to determine the utility of point-of-care ultrasound in the assessment of difficult laryngoscopy. Acad Emerg Med. 2011 Jul;18(7):754-8. doi: 10.1111/j.1553-2712.2011.01099.x. Epub 2011 Jun 27. Blaivas M, Tsung JW. Point-of-care sonographic detection of left endobronchial main stem intubation and…
Thank you for sharing this Journal of Clinical Microbiology article.. NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.. ...
CD4+ T cell counts are important tests used to stage HIV-postive patients, enabling clinicians to make informed antiretroviral treatment decisions and to monitor the therapeutic outcomes. However, state-of-the-art CD4 counting methods based on flow cytometry are not applicable in resource-limited settings, d
Semantic Scholar extracted view of Point-of-care glucose testing in critically ill patients: visual logistics and a glycemic variability hypothesis. by Gerald J. Kost et al.
Background-Cardiac surgery is frequently complicated by coagulopathic bleeding that is difficult to optimally manage using standard hemostatic testing. We hypothesized that point-of-care hemostatic testing within the context of an integrated transfusion algorithm would improve the management of coagulopathy in cardiac surgery and thereby reduce blood transfusions. Methods-We conducted a pragmatic multi-centered stepped-wedge cluster randomized controlled trial of a POC-based transfusion algorithm in consecutive patients undergoing cardiac surgery with cardiopulmonary bypass at 12 hospitals from Oct 6, 2014 to May 1, 2015. Following a 1-month data collection at all participating hospitals, a transfusion algorithm incorporating point-of-care hemostatic testing was sequentially implemented at 2 hospitals at a time in 1-month intervals, with the implementation order randomly assigned. No other aspects of care were modified. The primary outcome was red cell transfusion from surgery to postoperative ...
The Siemens DCA Vantage point-of-care analyzer an ideal option for diabetes management in physicians offices, point-of-care coordinated sites in hospitals, and multisite practices. Fast a...
By Asal Golshaie and Christian Donohoe. When the team first met, we only knew that we had ten weeks to use genetic engineering to "make something useful". The rest was up to us. We bounced some ideas around, from synthetic honey to a treatment for gastric cancer. Eventually we settled on the idea of improving the diagnosis of sexually transmitted infections (STIs), alert to national cuts to sexual health spending and Cardiff Universitys poor ranking for sexual healthcare.. Specifically, we set out to develop a novel point-of-care test for STIs: a faster, cheaper, and more specific alternative to sending samples for lab testing. A diagnostic test has two components: detection and reporting. For the detection of STI specific DNA, we turned to CRISPR-Cas9, a revolutionary gene editing tool based on the innate immune system of bacteria. For reporting, we relied on fluorescent proteins: they glow a certain colour when active, and are often fused to genes to follow their activity. We also evaluated ...
4. Münchner Point-of-Care Testing Symposium Point-of-Care Testing im Spannungsfeld von neuartigen Technologien und klinischen Applikationen|br /|11.-13. März 2019 | München
Video articles in JoVE about heparin low molecular weight include Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood.
Radisens Diagnostics Ltd.( Radisens) is a medical diagnostics company. Radisens develops disruptive point-of-care diagnostic platforms and multiplexed test panels, which diagnose and monitor patients for multiple chronic and acute care conditions. This point-of-care platform integrates immunoassay, biochemistry and cellular haematology onto a single test panel. It monitors chronic diseases such as diabetes, heart disease, kidney and thyroid function, and cell counting, amongst others. Using disruptive patent pending technology, it delivers the significant market and clinical need for decentralizing diagnostics into point of care settings such as doctors offices, outpatient and emergency room departments, intensive care units and hospital. Radisens has additional office in Boston, Massachusetts. The company is headquartered at Cork, Ireland. This report is a source for data, analysis and actionable intelligence on the Radisens Diagnostics Ltd. portfolio of pipeline products. The report provides
We were able to determine that point-of-care and rapid tests in oral fluids and blood ranged in accuracy from 97 to 99 per cent, which is significant," says senior author, Dr. Nitika Pant Pai, Assistant Professor in the Department of Medicine at McGill University and clinical researcher at the RI MUHC. "With their quick turnaround time and convenience we can now use these tests to screen many patients worldwide." Although conventional lab testing is in place in developed countries, it is available only to those who visit community clinics and specialized hospitals and have a risk profile, or symptomatology, that warrant screening. Typically, results are available within a week, but may only be communicated to the patient during their next visit, which may be one to three months later. Delays like this may result in reduced patient follow-up and potentially impact transmission of the virus in the community. Accurate and reliable point-of-care tests and rapid tests offer an alternative to standard ...
This report studies the China Point-of-care Testing (POCT) Market status and outlook of global and United States, from angles of players, regions, product
Astrotech (NASDAQ: ASTC) subsidiary 1st Detect announces successful pre-clinical trials for mass spectrometer used as a rapid bedside breathalyzer.
Sébastien Ponsonnard, Simon Karoutsos, Emmanuel Gardet, Jean-Philippe Marsaud and Nathalie Nathan-Value of Lung Sonography to Control Right-Sided Double Lumen Endotracheal Tube Location
EUnetHTA is pleased to announce that the project plan and and comments from external experts for the Other Technologies Collaborative Assessment OTCA22 "Clinical utility of Point-of-care Tests (POCT) D-Dimer and Troponin are now available for access. The final assessment report will ...
Abstract Background: Rapid technological progress in point-of-care testing allows the measurement of multiple analytes in whole-blood samples. The present study evaluated biosensor-based methods for the measurement of electrolytes and substrates in whole blood using a Stat Profile Critical Care Xpress (Nova Biomedical, Waltham, MA, USA) multiprofile analyzer and their comparability with standard laboratory methods. Because of the increased utilization of arterial blood samples in hospitalized patients and limited information on differences between arterial and venous blood for most routine laboratory tests, analytical differences caused by different sample types were evaluated. Methods: Whole-blood arterial samples and venous serum samples were obtained from 70 random patients with a variety of diagnoses admitted to the intensive care unit. The Stat Profile Critical Care Xpress analyzer was used to obtain whole-blood electrolyte and substrate profiles. For comparison studies, plasma or serum samples
The global blood gas and electrolyte analyzers market is expected to grow at a CAGR of 4.7% during the forecast period (2016-2024).Rise in diseases such as cancer, obesity, diabetes, and respiratory disorders can drive the market during the forecast period (2016 to 2024). These devices help in the diagnosis of diseases, such as chronic obstructive pulmonary disease (COPD), drug overdose, and asthma among others. Demand for portable devices, introduction of newer technologies, and rising healthcare expenditure can impel the industry. Moreover, multi-parameter monitoring devices could favor industry growth.. Increasing geriatric population will also propel market growth. As per the World Health Organization (WHO), the population belonging to the age group of 65 years & above may rise to 16% by 2050 from 7% in 2000. This in turn can increase the demand for point-of-care diagnostic testing which can positively impact the global market in the long run. Lack of trained professionals is a major ...
A recent article from prweb disclosed the FDAs clearance of InBios Chagas Detect Plus (CDP) Rapid Diagnostic Test Kit. CDP is the first point-of-care rapid in vitro diagnostic device to receive the FDAs 510K Clearance. CDP is a simple non-invasive test consisting of just two steps that yield results in roughly 20 minutes with 95% sensitivity and specificity. The kit can be stored at room temperature for up to two years. ...
Jamaica Hospital was one of only a handful of hospitals in New York State, and the only one in Queens to obtain ACEPs Clinical Ultrasound Accreditation. This designation is a testament to the continued high quality of care provided by Jamaica Hospitals Emergency Department. According to Celine Thum, MD, FAAEM, Director of Emergency Ultrasound, "Point-of-care ultrasound is an integral part of how emergency care is delivered at Jamaica Hospital and has already had a positive impact on our patients. Our doctors have used this technology to identify emergent pathologies in patients, which has resulted in positive outcomes and lives saved.". Geoffrey Doughlin, MD, Chairman of Emergency Medicine added, "We are proud to have achieved this accreditation by the American College of Emergency Physicians as it demonstrates that Jamaica Hospital is among the best in the world at delivering point-of-care emergency ultrasound.". All content of this newsletter is intended for general information purposes only ...
HPV and cervical cancer remain incredibly important topics for detailed study by all post graduates. Again, these papers are available as free text via the PUBMED links provided. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens. J Clin Microbiol. 2016 Jul;54(7):1734-7. Toliman P et…
Also known as portable or bedside ultrasound, point-of-care ultrasound is conducted using a lightweight system similar to a laptop computer with a connected hand-held probe (also called a transducer). If you have a pain or an injury, we can look "inside" immediately by placing the small probe against your skin to view (scan) the area. We use a special liquid gel between the transducer and your skin to improve the ultrasound signal. High-frequency sound waves, conceptually similar to sonar used by animals such as bats and dolphins, are pulsed through the spot and, when they hit various anatomical objects or boundaries, they bounce back to the transducer and are relayed to the ultrasound system to create a live image on the monitor. With recent technological advances, image rendering can produce fine anatomical detail, enabling physicians to localize structures such as nerves, muscles, and joints with exceptional clarity. The keen visualization obtained by ultrasound imagery allows the physician ...
The COVID-19 IgG / IgM Rapid test is a 10 minute instant Point-of-care test device for the qualitative detection of IgM and IgG antibodies specific to 2019-nCoV in human whole blood, serum or plasma specimens.. CLICK HERE TO REVIEW THE TEST AND ITS SPECIFICATIONS. CLICK HERE TO SEE OUR TEST IN A CASE PRESENTATION OF A PREVIOUSLY POSITIVE CoV-19 Subject.. ...
Hall MK, Hall J, Gross CP, Harish NJ, Liu R, Maroongroge S, Moore CL, Raio CC, Taylor RA: Use of Point-of-Care Ultrasound in the Emergency Department: Insights From the 2012 Medicare National Payment Data Set. J Ultrasound Med. 2016 Nov; 2016 Oct 3. PMID: 27698180 Pare JR, Liu R, Moore CL, Safdar B: Corrected flow time: a noninvasive ultrasound measure to detect preload reduction by nitroglycerin. Am J Emerg Med. 2016 Sep; 2016 Jun 24. PMID: 27431739 Daniels B, Gross CP, Molinaro A, Singh D, Luty S, Jessey R, Moore CL: STONE PLUS: Evaluation of Emergency Department Patients With Suspected Renal Colic, Using a Clinical Prediction Tool Combined With Point-of-Care Limited Ultrasonography. Ann Emerg Med. 2016 Apr; 2015 Dec 31. PMID: 26747219 Pare JR, Liu R, Moore CL, Sherban T, Kelleher MS Jr, Thomas S, Taylor RA: Emergency physician focused cardiac ultrasound improves diagnosis of ascending aortic dissection. Am J Emerg Med. 2016 Mar; 2015 Dec 12. PMID: 26782795 Moore CL, Daniels B, Gross CP, Luty ...
... Published by VPGMarketResearch.com at researchbeam.com [Report Price $16600] 1230 Pages
Infection and tissue damage lead to release of signaling proteins into the bloodstream of the patient. An ability to rapidly analyze panels of these so-called host response markers can enable new diagnostic and prognostic approaches that can potentially lead to significantly more effective patient management during the time-critical phase of acute infection. According to MBio CEO Chris Myatt, "Managing acute infections accurately and quickly is a critical task in the healthcare system. MBio brings a unique approach to testing that provides multiple, high-sensitivity quantitative results in a simple, point-of-care device. Our goal is to help transform the management of severely ill individuals by delivering biomarker panel results in minutes in the emergency department or intensive care unit, rather than waiting hours for laboratory tests." Dr. Myatt added on the Cincinnati collaboration, "Adapting high-value content, such as derived from Dr. Wongs outstanding investigations of pediatric and ...
Dr Ellen Jo Baron, Emeritus Professor of Pathology at the Stanford University Medical Center and associated with Cepheid, gave the example of Cepheids Xpert HIV1 Viral Load assay which is strictly not a point-of-care test. But it can be done in a small laboratory that has necessary resources. It is fully automated, can identify all the sub-types and gives results in 90 minutes. Dr Baron shared that Cepheid has got a grant to create a finger-stick test for viral load testing, which is battery operated, portable, rugged, relatively affordable, can be run on omni instrument at remote sites. It is hoped to give results in less than 60 minutes, with an accuracy of 500 copies/ml ...
Point-of-Care/POC Drugs of Abuse Testing Market, 2019-2023: Supplier Shares, Competitive Strategies, Country Segment Forecasts for 12 Drugs, Innovative Technologies, Instrumentation Review
BACKGROUND: Despite the fact that a large proportion of children with fever in Africa present at primary health care facilities, few studies have been designed to specifically study the causes of uncomplicated childhood febrile illness at this level of care, especially in areas like Zanzibar that has recently undergone a dramatic change from high to low malaria transmission. METHODS: We prospectively studied the aetiology of febrile illness in 677 children aged 2-59 months with acute uncomplicated fever managed by IMCI (Integrated Management of Childhood Illness) guidelines in Zanzibar, using point-of-care tests, urine culture, blood-PCR, chest X-ray (CXR) of IMCI-pneumonia classified patients, and multiple quantitative (q)PCR investigations of nasopharyngeal (NPH) (all patients) and rectal (GE) swabs (diarrhoea patients ...
BACKGROUND: The development of digital health solutions for current health care settings requires an understanding of the complexities of the health care system, organizational setting, and stakeholder groups and of the underlying interplay between stakeholders and the technology. The digital health solution was founded on the basis of an information and communication technology platform and point-of-care devices enabling home-based monitoring of disease progression and treatment outcome for patients with rheumatoid arthritis (RA).. OBJECTIVE: The aim of this paper is to describe and discuss the applicability of an iterative evaluation process in guiding the development of a digital health solution as a technical and organizational entity in three different health care systems.. METHODS: The formative evaluation comprised the methodologies of contextual understanding, participatory design, and feasibility studies and included patients, healthcare professionals, and hardware and software ...
Now dont take away that I am opposed to bedside ultrasound -- I love it. I recently diagnosed a ruptured cornual pregnancy with it, and having that capability really expedited the patient to the OR. I dont use it every shift, but pretty frequently. I was highly instrumental in convincing our hospital to purchase it. But the business plan -- the cost/benefit -- is a challenging argument to make to administration. "Well, Mr CEO, Id like you to spend $50,000 to buy a machine that wont bring in any additional revenue, will be used infrequently, and is guaranteed to piss off the radiologists." We sold it based on quality of care and patient safety, especially for the infrequent cases where it really can be lifesaving, and we are lucky enough to have collaborative radiologists who work well with us on this issue. So we won that round. But I cant bring myself to be too critical of the ED director who chooses other matters to expend political capital over, especially in a smaller ED ...
25 Jan 2017/in Uncategorized /by Tracey Keisch. CAMBRIDGE, Mass. - January 25, 2017 - Daktari Diagnostics, a company focused on making "Anywhere. Care.™" a reality with its portable and ultrasensitive immunoassay-based CarePlatform™, today announced that it has reached a milestone in its global collaboration with Merck, known as MSD outside the United States and Canada, for the development of Daktaris rapid point-of-care (POC) hepatitis C virus (HCV) core antigen confirmatory test system.[Daktari Achieves Milestone in Its Merck HCV Collaboration ...
The ResPOC study demonstrated that syndromic molecular point-of-care testing (POCT) for respiratory viruses was associated with early discontinuation of unneces...
Global Flow Cytometry Market is expected to reach USD 8.0 billion by 2025, according to a new study by Grand View Research, Inc. The increasing incidence of infectious diseases and cancer is expected to upsurge the demand for flow cytometers for use in disease diagnosis over the coming years. In addition, higher number of physicians is inclined toward the usage of autologous and allogenic stem cell therapy, due to adverse effects caused by chemotherapy & radiation therapy in the treatment of cancer, thereby affecting the growth of this market.. Moreover, rising demand for point-of-care testing in chronic diseases management is expected to fuel the demand for cytometry techniques. Rising implementation of microfluidic miniature flow cytometry in point-of-care diagnostics is the factor augmenting the future growth. Increasing R&D initiatives by various key players for the development of multicolor assays and advanced reagents for analysis are anticipated to boost the usage rate. Advancement in ...
To the Editor The authors of the JAMA Diagnostic Test Interpretation article on point-of-care (POC) testing for vitamin K antagonist monitoring suggested confir
This ultrasound training video is designed to review venous anatomy/physiology, imaging techniques and diagnostic criteria for performing a focused venous ultrasound exam for point-of-care applications.
Trusted information for laboratory scientists about Point-of-care lab products and techniques on SelectScience, including services, kits, analyzers and software.
Shop for point-of-care testing standards education products from CLSI. Find the standards and educational materials from CLSI that match your discipline.